The global market for Rabies Vaccine was valued at US$ 1006 million in the year 2024 and is projected to reach a revised size of US$ 1319 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Rabies Vaccine Market

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.

The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rabies Vaccine Market Report

Report Metric	Details
Report Name	Rabies Vaccine Market
Accounted market size in year	US$ 1006 million
Forecasted market size in 2031	US$ 1319 million
CAGR	4.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Vero Cell Rabies Vaccine BHK Chick Embryo Cell Rabies Vaccine Others
Segment by Application	Pre-exposure Prophylaxis Post-exposure Prophylaxis
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Rabies Vaccine Market growing?

Ans: The Rabies Vaccine Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Rabies Vaccine Market size in 2031?

Ans: The Rabies Vaccine Market size in 2031 will be US$ 1319 million.

What is the market share of major companies in Rabies Vaccine Market?

Ans: Global top four manufacturers hold a share about 70%.

What is the Rabies Vaccine Market share by type?

Ans: In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%.

Who are the main players in the Rabies Vaccine Market report?

Ans: The main players in the Rabies Vaccine Market are GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen

What are the Application segmentation covered in the Rabies Vaccine Market report?

Ans: The Applications covered in the Rabies Vaccine Market report are Pre-exposure Prophylaxis, Post-exposure Prophylaxis

What are the Type segmentation covered in the Rabies Vaccine Market report?

Ans: The Types covered in the Rabies Vaccine Market report are Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Others

1 Rabies Vaccine Market Overview

1.1 Product Definition

1.2 Rabies Vaccine by Type

1.2.1 Global Rabies Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Vero Cell Rabies Vaccine

1.2.3 BHK

1.2.4 Chick Embryo Cell Rabies Vaccine

1.2.5 Others

1.3 Rabies Vaccine by Application

1.3.1 Global Rabies Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Pre-exposure Prophylaxis

1.3.3 Post-exposure Prophylaxis

1.4 Global Rabies Vaccine Market Size Estimates and Forecasts

1.4.1 Global Rabies Vaccine Revenue 2020-2031

1.4.2 Global Rabies Vaccine Sales 2020-2031

1.4.3 Global Rabies Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Rabies Vaccine Market Competition by Manufacturers

2.1 Global Rabies Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Rabies Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Rabies Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Rabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rabies Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rabies Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Rabies Vaccine, Date of Enter into This Industry

2.8 Global Rabies Vaccine Market Competitive Situation and Trends

2.8.1 Global Rabies Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Rabies Vaccine Players Market Share by Revenue

2.8.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Rabies Vaccine Market Scenario by Region

3.1 Global Rabies Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Rabies Vaccine Sales by Region: 2020-2031

3.2.1 Global Rabies Vaccine Sales by Region: 2020-2025

3.2.2 Global Rabies Vaccine Sales by Region: 2026-2031

3.3 Global Rabies Vaccine Revenue by Region: 2020-2031

3.3.1 Global Rabies Vaccine Revenue by Region: 2020-2025

3.3.2 Global Rabies Vaccine Revenue by Region: 2026-2031

3.4 North America Rabies Vaccine Market Facts & Figures by Country

3.4.1 North America Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Rabies Vaccine Sales by Country (2020-2031)

3.4.3 North America Rabies Vaccine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Rabies Vaccine Market Facts & Figures by Country

3.5.1 Europe Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Rabies Vaccine Sales by Country (2020-2031)

3.5.3 Europe Rabies Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rabies Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Rabies Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Rabies Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Rabies Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Rabies Vaccine Market Facts & Figures by Country

3.7.1 Latin America Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Rabies Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Rabies Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Rabies Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Rabies Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rabies Vaccine Sales by Type (2020-2031)

4.1.1 Global Rabies Vaccine Sales by Type (2020-2025)

4.1.2 Global Rabies Vaccine Sales by Type (2026-2031)

4.1.3 Global Rabies Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Rabies Vaccine Revenue by Type (2020-2031)

4.2.1 Global Rabies Vaccine Revenue by Type (2020-2025)

4.2.2 Global Rabies Vaccine Revenue by Type (2026-2031)

4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Rabies Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Rabies Vaccine Sales by Application (2020-2031)

5.1.1 Global Rabies Vaccine Sales by Application (2020-2025)

5.1.2 Global Rabies Vaccine Sales by Application (2026-2031)

5.1.3 Global Rabies Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Rabies Vaccine Revenue by Application (2020-2031)

5.2.1 Global Rabies Vaccine Revenue by Application (2020-2025)

5.2.2 Global Rabies Vaccine Revenue by Application (2026-2031)

5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Rabies Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GSK (Novartis)

6.1.1 GSK (Novartis) Company Information

6.1.2 GSK (Novartis) Description and Business Overview

6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio

6.1.5 GSK (Novartis) Recent Developments/Updates

6.2 Sanofi-Pasteur

6.2.1 Sanofi-Pasteur Company Information

6.2.2 Sanofi-Pasteur Description and Business Overview

6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio

6.2.5 Sanofi-Pasteur Recent Developments/Updates

6.3 Chengda

6.3.1 Chengda Company Information

6.3.2 Chengda Description and Business Overview

6.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Chengda Rabies Vaccine Product Portfolio

6.3.5 Chengda Recent Developments/Updates

6.4 Yisheng

6.4.1 Yisheng Company Information

6.4.2 Yisheng Description and Business Overview

6.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Yisheng Rabies Vaccine Product Portfolio

6.4.5 Yisheng Recent Developments/Updates

6.5 Prcmise

6.5.1 Prcmise Company Information

6.5.2 Prcmise Description and Business Overview

6.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Prcmise Rabies Vaccine Product Portfolio

6.5.5 Prcmise Recent Developments/Updates

6.6 VACN

6.6.1 VACN Company Information

6.6.2 VACN Description and Business Overview

6.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 VACN Rabies Vaccine Product Portfolio

6.6.5 VACN Recent Developments/Updates

6.7 Changsheng

6.7.1 Changsheng Company Information

6.7.2 Changsheng Description and Business Overview

6.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Changsheng Rabies Vaccine Product Portfolio

6.7.5 Changsheng Recent Developments/Updates

6.8 BCHT

6.8.1 BCHT Company Information

6.8.2 BCHT Description and Business Overview

6.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 BCHT Rabies Vaccine Product Portfolio

6.8.5 BCHT Recent Developments/Updates

6.9 Hissen

6.9.1 Hissen Company Information

6.9.2 Hissen Description and Business Overview

6.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Hissen Rabies Vaccine Product Portfolio

6.9.5 Hissen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rabies Vaccine Industry Chain Analysis

7.2 Rabies Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rabies Vaccine Production Mode & Process Analysis

7.4 Rabies Vaccine Sales and Marketing

7.4.1 Rabies Vaccine Sales Channels

7.4.2 Rabies Vaccine Distributors

7.5 Rabies Vaccine Customer Analysis

8 Rabies Vaccine Market Dynamics

8.1 Rabies Vaccine Industry Trends

8.2 Rabies Vaccine Market Drivers

8.3 Rabies Vaccine Market Challenges

8.4 Rabies Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rabies Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Rabies Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Rabies Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Rabies Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Rabies Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Rabies Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Rabies Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Rabies Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Rabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rabies Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rabies Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Rabies Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Rabies Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Rabies Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Rabies Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Rabies Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Rabies Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Rabies Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Rabies Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Rabies Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Rabies Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Rabies Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Rabies Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Rabies Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Rabies Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Rabies Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Rabies Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Rabies Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Rabies Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Rabies Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Rabies Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Rabies Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Rabies Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Rabies Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Rabies Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Rabies Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Rabies Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Rabies Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Rabies Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Rabies Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Rabies Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Rabies Vaccine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Rabies Vaccine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Rabies Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Rabies Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Rabies Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Rabies Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Rabies Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Rabies Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Rabies Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Rabies Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Rabies Vaccine Price (USD/Unit) by Application (2020-2025)

Table 69. Global Rabies Vaccine Price (USD/Unit) by Application (2026-2031)

Table 70. GSK (Novartis) Company Information

Table 71. GSK (Novartis) Description and Business Overview

Table 72. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. GSK (Novartis) Rabies Vaccine Product

Table 74. GSK (Novartis) Recent Developments/Updates

Table 75. Sanofi-Pasteur Company Information

Table 76. Sanofi-Pasteur Description and Business Overview

Table 77. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Sanofi-Pasteur Rabies Vaccine Product

Table 79. Sanofi-Pasteur Recent Developments/Updates

Table 80. Chengda Company Information

Table 81. Chengda Description and Business Overview

Table 82. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Chengda Rabies Vaccine Product

Table 84. Chengda Recent Developments/Updates

Table 85. Yisheng Company Information

Table 86. Yisheng Description and Business Overview

Table 87. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Yisheng Rabies Vaccine Product

Table 89. Yisheng Recent Developments/Updates

Table 90. Prcmise Company Information

Table 91. Prcmise Description and Business Overview

Table 92. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Prcmise Rabies Vaccine Product

Table 94. Prcmise Recent Developments/Updates

Table 95. VACN Company Information

Table 96. VACN Description and Business Overview

Table 97. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. VACN Rabies Vaccine Product

Table 99. VACN Recent Developments/Updates

Table 100. Changsheng Company Information

Table 101. Changsheng Description and Business Overview

Table 102. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Changsheng Rabies Vaccine Product

Table 104. Changsheng Recent Developments/Updates

Table 105. BCHT Company Information

Table 106. BCHT Description and Business Overview

Table 107. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. BCHT Rabies Vaccine Product

Table 109. BCHT Recent Developments/Updates

Table 110. Hissen Company Information

Table 111. Hissen Description and Business Overview

Table 112. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Hissen Rabies Vaccine Product

Table 114. Hissen Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Rabies Vaccine Distributors List

Table 118. Rabies Vaccine Customers List

Table 119. Rabies Vaccine Market Trends

Table 120. Rabies Vaccine Market Drivers

Table 121. Rabies Vaccine Market Challenges

Table 122. Rabies Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Rabies Vaccine

Figure 2. Global Rabies Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rabies Vaccine Market Share by Type: 2024 & 2031

Figure 4. Vero Cell Rabies Vaccine Product Picture

Figure 5. BHK Product Picture

Figure 6. Chick Embryo Cell Rabies Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Rabies Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Rabies Vaccine Market Share by Application: 2024 & 2031

Figure 10. Pre-exposure Prophylaxis

Figure 11. Post-exposure Prophylaxis

Figure 12. Global Rabies Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Rabies Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global Rabies Vaccine Sales (2020-2031) & (K Units)

Figure 15. Global Rabies Vaccine Average Price (USD/Unit) & (2020-2031)

Figure 16. Rabies Vaccine Report Years Considered

Figure 17. Rabies Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global Rabies Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Rabies Vaccine Players: Market Share by Revenue in Rabies Vaccine in 2024

Figure 20. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Rabies Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Rabies Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America Rabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Rabies Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe Rabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Rabies Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Rabies Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Rabies Vaccine Sales Market Share by Country (2020-2031)

Figure 45. Latin America Rabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Rabies Vaccine Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Rabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Rabies Vaccine by Type (2020-2031)

Figure 55. Global Revenue Market Share of Rabies Vaccine by Type (2020-2031)

Figure 56. Global Rabies Vaccine Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Rabies Vaccine by Application (2020-2031)

Figure 58. Global Revenue Market Share of Rabies Vaccine by Application (2020-2031)

Figure 59. Global Rabies Vaccine Price (USD/Unit) by Application (2020-2031)

Figure 60. Rabies Vaccine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions